The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Vasotop 2.5 mg tablets

Intervet Ireland LimitedVPA10996/138/002

Main Information

Trade NameVasotop 2.5 mg tablets
Active SubstancesRamipril
Dosage FormTablet
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/138/002

Group Information

ATC CodeQC09AA05 ramipril
Therapeutic ClassCardiovascular


Licence Issued27/10/2000
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back